🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07311889
Enrolling by invitation Observational

Patient Satisfaction and Recovery Outcomes Associated With Perioperative ELIXIR MD Use

NCT07311889 · tracked via the Priya Life Science USA tracker
Sponsor
Elixir MD Inc
Phase
Observational
Started
2026-01-19
Last updated
2026-08-24

Condition(s) studied

Postoperative PainPostoperative EdemaPostoperative EcchymosisSurgical Wound HealingPostsurgical Recovery

Investigational drug(s) / intervention(s)

Perioperative photobiomodulation light therapy

Perioperative photobiomodulation light therapy: Participants may receive perioperative light therapy as part of routine clinical care at the discretion of their treating clinician. The study does not assign, modify, or mandate the use of light therapy. Data are collected observationally to describe recovery outcomes associated with standard clinical practice.

Study summary

The goal of this observational registry study is to characterize postoperative recovery outcomes in adult patients receiving standard-of-care perioperative light therapy using an FDA-cleared photobiomodulation device as part of routine clinical practice. The study aims to describe changes in patient-reported and clinician-assessed recovery measures following elective surgical procedures.

The main questions this registry aims to answer are:

1. How do patient-reported recovery outcomes, including pain, satisfaction, and perceived improvement, change over the postoperative period?
2. How do clinician-assessed indicators of recovery, such as swelling and bruising, change over time following surgery?

This study does not include a randomized comparison group. Outcomes will be described longitudinally within participants based on data collected during routine care.

Participants will:

1. Receive perioperative light therapy as part of standard clinical care, per their treating clinician
2. Complete patient-reported outcome questionnaires at defined postoperative time points
3. Undergo standardized clinical photography and routine clinical assessments as part of usual follow-up

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Adults aged 18 years or older undergoing elective plastic surgery (facial or body procedures) at a participating plastic surgery practice where the ELIXIR MD™ device is used as part of standard perioperative care. * Able to provide informed consent and complete brief patient-reported questionnaires. Exclusion Criteria: * Pregnancy. * Basal cell carcinoma, thyroid disorders, or malignant tumors. * History of photosensitive skin disease or photosensitivity. * Epilepsy or seizure disorders. * Recent use of photosensitizing medications, including isotretinoin within the past 6 months; tetracyclines or ciprofloxacin within the past 5 days; chlorpromazine within the past 8 days; methotrexate within the past 3 days; or amiodarone, per physician discretion.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
ELIXIR MD Inc Irvine California

More Elixir MD Inc trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07311889 on ClinicalTrials.gov ↗ ← All trials in the USA